SCHEMBL23992718

SCHEMBL23992718

CCC(CO)Nc1nc(N(C)c2ccc(OC)cc2)c2ncn(C(C)C)c2n1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPSR1 Q6W5P4 1/20 0.59
▸ CDK1 P06493 8/20 0.56
▸ CDK2 P24941 16/20 0.54
▸ CCNE1 P24864 9/20 0.54
▸ CDK5 Q00535 9/20 0.54
▸ DYRK1A Q13627 8/20 0.54
▸ CCNA2 P20248 7/20 0.54
▸ CCNA1 P78396 7/20 0.54
▸ CDK5R1 Q15078 7/20 0.54
▸ CCNB1 P14635 5/20 0.54
▸ CCNE2 O96020 2/20 0.53
▸ CDK7 P50613 4/20 0.53
▸ CDK9 P50750 3/20 0.53
▸ CSNK1D P48730 2/20 0.53
▸ CLK2 P49760 2/20 0.53
▸ CSNK1G2 P78368 2/20 0.53
▸ CLK4 Q9HAZ1 2/20 0.53
▸ CSNK1G1 Q9HCP0 2/20 0.53
▸ CCNB2 O95067 2/20 0.53
▸ CDK4 P11802 2/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15387291 1.00 NPSR1 (0.59) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL23993161 0.90 CDK1 (0.65) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL19112453 0.89 NPSR1 (0.60) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL19112171 0.89 NPSR1 (0.60) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL15387124 0.89 NPSR1 (0.67) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL19112178 0.89 NPSR1 (0.67) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL19112192 0.89 NPSR1 (0.67) NPSR1CDK1CDK2CCNE1CDK5
SCHEMBL30356263 0.89 NPSR1 (0.67) NPSR1CDK1CDK2CCNE1CDK5
Hydrochloric Acid SCHEMBL23927317 0.88 NPSR1 (0.66) NPSR1CDK1CDK2CCNE1CDK5
Hydrochloric Acid SCHEMBL23927315 0.88 NPSR1 (0.66) NPSR1CDK1CDK2CCNE1CDK5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3901154-A1 PURINE DERIVATIVES AS DRUGS FOR THE TREATMENT OF NEONATAL HYPOXIA-ISCHEMIA BRAIN INJURY AND RELATED DISEASES Commissariat à l'énergie atomique et aux énergies alternatives (FR) 2021-10-27 — — EP disclosed
Send feedback